Translational Science

Oncology research has come a long way over the past 30 years, but we must transform outdated practices to further improve drug discovery innovation.

Male animal bias in preclinical research isn’t scientifically justified and may be skewing our understanding of the brain.

A new vaccine could help give people at risk of HIV more options.

Sitting Down With… Joan Mannick, Co-Founder and Chief Medical Officer at resTORbio, Massachusetts, USA.

Can the innate immune system be reprogrammed to fight cancer? Inmune Bio believes the answer is yes.

When art and science meet, true inspiration can be found and tapped into.

Will antibody drug conjugates live up to the ever-growing expectations surrounding them?

Claudia Zylberberg reveals her career lessons learned and offers her perspective on the now booming advanced therapies industry.

How do we battle gut bacteria that reduce medicine efficacy?

The game “Tumor Quest” seeks to improve people’s understanding of cancer.